LEP and endometrial cancer: After analyzing the results of our study, it appears that both leptin and FGF21 will predict the stage of tumor progression well, which correlates with the possibility of performing a smaller range (scope) of surgeries in patients who are often obese and burdened with diseases associated to endometrial cancer.